𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck

✍ Scribed by Susanne Koy; Martin Hauses; Hella Appelt; Katrin Friedrich; Hans K. Schackert; Uwe Eckelt


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
227 KB
Volume
26
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background.

ZAC/Lot1 is a previously identified candidate tumor suppressor gene. The gene maps to the human chromosome 6q24‐q25, a region frequently deleted in squamous cell carcinomas of the head and neck and other solid tumors.

Methods.

We have used a model of head and neck squamous cell carcinoma (HNSCC) and cell lines to analyze the role of the candidate tumor suppressor gene ZAC/Lot1 in oral carcinogenesis. We analyzed the expression in 11 cell lines, and we performed loss of heterozygosity (LOH)‐ and sequence analyses in 51 primary tumors.

Results.

Three (27.3%) of 11 cell lines showed a distinctly reduced expression of ZAC/Lot1 compared with expression levels of the gene in the normal oral mucosa. In addition, we analyzed 51 primary squamous cell carcinomas of the head and neck for LOH with seven microsatellite markers flanking ZAC/Lot1. We detected an average LOH rate of 31.4% in the region of interest. Sequence analysis revealed no mutations for the ZAC/Lot1 coding exons, including the exon/intron boundaries.

Conclusions.

These data could suggest a minimal role for ZAC/Lot1 in a subgroup of HNSCC tumors. Β© 2004 Wiley Periodicals, Inc. Head Neck 26: 338–344, 2004


πŸ“œ SIMILAR VOLUMES


Expression of cancer testis antigens in
✍ David L. A. Figueiredo; Rui C. M. Mamede; Rodrigo Proto-Siqueira; Luciano Neder; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 2 views

## Abstract ## Background. There is considerable interest in the expression of cancer testis (CT) antigens in human cancers, because they may serve as the basis for diagnostic tests or an immunologic approach to therapy, or as prognostic markers. ## Methods. On this basis, we evaluated by semiqu

Role of squamous cell carcinoma antigen
✍ Torahiko Nakashima; Ryuji Yasumatsu; Yuichiro Kuratomi; Muneyuki Masuda; Takashi πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 202 KB πŸ‘ 2 views

## Background: Serine proteases have important roles in tumor invasion and metastasis, and their inhibitors, serine protease inhibitors (serpins), are attractive targets for therapeutic strategies. on chromosome 18q21, there is a cluster of serpins: maspin, headpin, and squamous cell carcinoma anti

Frequent expression of Niban in head and
✍ Shin Ito; Hiroaki Fujii; Toshiharu Matsumoto; Masaaki Abe; Katsuhisa Ikeda; Okio πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 2 views

## Abstract ## Background Niban was initially identified in the Eker rat, a model of renal carcinogenesis. We examined Niban expression in head and neck squamous cell carcinoma (HNSCC) and head and neck dysplastic lesions. ## Methods Using a polyclonal rabbit anti‐human Niban antibody, 43 cases

Loss of imprinting and loss of heterozyg
✍ ClΓ‘udia A. Rainho; Luiz P. Kowalski; Silvia R. Rogatto πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

## Abstract ## Background __IGF2__ and __H19__ are reciprocal imprinted genes with paternal and maternal monoallelic expression, respectively. This is interesting, because __IGF2__ is known as a growth factor, and __H19__ encodes a RNA with putative tumor suppressor action. Furthermore, __IGF2__ a

Bcl-xL and Bcl-2 expression in squamous
✍ John C. Pena; Craig B. Thompson; Wendy Recant; Everett E. Vokes; Charles M. Rudi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 234 KB πŸ‘ 2 views

## Background: Inhibition of apoptosis, or programmed cell death, may be critical both in the development of cancer and in determining response to therapy. the authors examined the expression of two related apoptotic inhibitors, bcl-2 and bcl-xl, in pretreatment biopsies from a series of 42 patient